Financial News

Financial Report: AbbVie

HUMIRA sales up 14% to $4.7 billion in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

AbbVie 1Q Revenues: $7.9 billion (+21%) 1Q Earnings: $2.8 billion (+63%) Comments: Global HUMIRA sales were $4.7 billion, up 14%. IMBRUVICA sales were $762 million, up 39%. Global HCV sales were $919 million in the quarter, up more than 100%. Synagis sales were up 7% to $321 million. Duodopa sales were up 17% to $103 million. Kaletra sales continued to decline to $73 million, down 39% in the quarter.  ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters